Effective dates for CE credit: 11/16/2022 – 11/16/2024
This program will provide an update on currently available technology and its role in patient care as well as a look into what is expected to be FDA approved in the next 6-12 months. It will include case studies with medication management with use of continuous glucose sensing as well as insulin pump and hybrid closed loop management for patients with type 1 and type 2 diabetes.
Learners will have an increased knowledge of new technologies on the market and how to use the ICC Framework and DATAA Model to identify the appropriate technology for the person with diabetes.
At the end of this presentation, participants will be able to:
-- Discuss ADA/EASD Standards of Care and the use of technology
-- Discuss the ICC Framework: review right patient, right technology, right time concept
-- Discuss continuous glucose sensors, connected insulin pens, and smart pumps and their role in clinical practice including what is available now and what is on the horizon
-- Discuss challenges in keeping up with technology and resources available for clinicians
This recording of a live presentation is a knowledge-based learning activity.
This activity is designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).
Originally presented on: 11/16/2022
Expiration date: 11/16/2024